drugset
Drugs / Autologous Dendritic cell (ADC) vaccine
last change Sep 2025 re-read 9 days ago

Autologous Dendritic cell (ADC) vaccine

Vaccine

Developed for
small cell lung carcinoma
Investigated by
Fundacion Clinic per a la Recerca Biomédica · Instituto Oncológico Dr Rosell · Roche Pharma AG

Trials 1

today NCT04487756 · Ph 1/2
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04487756 Mar 2021 → Sep 2025 small cell lung carcinoma Instituto Oncológico Dr Rosell Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous Dendritic cell (ADC) vaccine “Autologous Dendritic cell (ADC) vaccine, Dendritic cell (DC) vaccine” NCT04487756 ↗
Modality Vaccine “autologous dendritic cell vaccine” NCT04487756 ↗
Route Other “DCV intradermally” NCT04487756 ↗